Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Ligtenberg, Marjolijn J L, Kuiper, Roland P, Chan, Tsun Leung, Goossens, Monique, Hebeda, Konnie M, Voorendt, Marsha, Lee, Tracy Y H, Bodmer, Danielle +10 more·2009·Nature Genetics
DOI 10.1038/ng.283

Cited by (827)

Items 701–800 of 827

  1. Évaluation de l'expression et de la valeur pronostique de PD-L1 dans les cancers colorectaux traités par chirurgie première : série rétrospective de 105 cas
    Gratiane Cogniet · 2016 · HAL
  2. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Epigenetics of Colorectal Cancer
    Ajay Goel, Clement Richard Boland · 2012
  3. THE NATURAL FLAVONOID LUTEOLIN INDUCES APOPTOSIS IN COLON CANCER CELLS BY DYSREGULATING THE SPHINGOLIPID RHEOSTAT
    ABDEL HADI, LOUBNA · 2014 · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
  4. Lifetime Colonic Polyp Rate Comparisons and the EPCAM Deletion
    Matthew C. Fadus, Henry T. Lynch, Carrie Snyder, Jahnavi Koppala · 2015
  5. Aus der Medizinischen Klinik Innenstadt der Ludwig-Maximilians-Universität München
    Martín Reincke · 2008
  6. Identification of the genetic basis of multicentric tumourigenesis
    James W. Whitworth · 2016 · University of Birmingham Institutional Research Archive (University of Birmingham)
  7. Allele-specific gene expression in carcinogenesis
    О. М. Кривцова, Natalia L. Lazarevich · 2016 · Advances in molecular oncology
  8. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications
    Nicole Lopez, Jen Jen Yeh · 2016 · Cancer treatment and research
  9. Regulation and epigenetic modulation of EpCAM gene expression in ovarian cancer
    Bernardina T.F. van der Gun · 2010
  10. The Role of Hereditary and Environmental Factors in Gastrointestinal Cancers
    Beth Dudley, Savreet Sarkaria, Randall E. Brand · 2016 · WORLD SCIENTIFIC eBooks
  11. Molecular Biomarker Discovery in Psoriatic Arthritis
    Remy A. Pollock · 2016 · TSpace (University of Toronto)
  12. Risikogruppen mit einer erblichen Disposition für kolorektale Karzinome
    Gabriela Möslein · 2016 · coloproctology
  13. Functional Analyses Help to Assess the Pathogenicity of MMR Gene Variants of Uncertain Significance
    Minna Nyström, Minttu Kansikas · 2013 · Springer eBooks
  14. Identification of Cancer Susceptibility Loci by High-resolution Cancer Gene Microarray Analysis
    Sudhir Jonathan Trick · 2014 · TSpace (University of Toronto)
  15. Von der Grundlagenforschung zur Routinediagnostik
    Ulrich Lehmann · 2010
  16. DNA and Histone Methylation in Colon Cancer
    Hiromu Suzuki, Eiichiro Yamamoto, Hiroshi Nakase, Tamotsu Sugai · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
  17. Assessment of Missense Alterations in MLH1 and their Pathogenic Significance
    Needra Sheron Perera · 2010 · TSpace (University of Toronto)
  18. Inherited BRCA1 epimutation as a novel cause of breast and ovarian cancer
    D. Gareth Evans, Elke Maria van Veen, Helen Byers, Andrew J. Wallace, Jamie M. Ellingford, Glenda M. Beaman, Javier Santoyo‐López, Timothy J. Aitman, Diana Eccles, Fiona I. Lalloo et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Influencia del estado nutricional e inflamatorio preoperatorio sobre las complicaciones tras cirugía curativa del cáncer colorrectal
    Martín Bailon Cuadrado · 2017
  20. Genetic Testing in Hereditary Colorectal Cancer
    C. Lázaro, L. Feliubadaló, J. del Valle · 2018 · Springer eBooks
  21. Attitudes Toward Updated Genetic Testing Among Patients with Unexplained Mismatch Repair Deficiency
    Jessica Omark · 2018
  22. An Integrative DNA Sequencing Panel To Assess Mismatch Repair Deficiency
    Leslie E. Oldfield · 2018 · TSpace (University of Toronto)
  23. Une épimutation transgénérationnelle du gène MMACHC produit un nouveau type d’erreur innée du métabolisme dénommée épi-cblC
    Jean‐Louis Guéant, Céline Chéry, Abderrahim Oussalah, J Nicolas, Jacek Majewski, David S. Rosenblatt · 2018 · Bulletin de l Académie Nationale de Médecine
  24. The Clinical Utility of Epigenetics: A Case Study
    Luke B. Hesson, Mathew A. Sloane, Antonia L. Pritchard · 2019 · Springer eBooks
  25. Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
    T. T. Andabekov, M. K. Rodina, Григорий Александрович Раскин, K. G. Cham, Игорь Олегович Руткин · 2019 · Tumors of female reproductive system
  26. Barriers and Facilitators in Health Care: Perspectives of Persons with Lynch Syndrome
    Kathleen Zawaly · 2019 · Mspace (University of Manitoba)
  27. Turcot Syndrome with Gliosarcoma: A rare variation of a Lynch Syndrome Phenotype
    2017 · ARC Journal of Clinical Case Reports
  28. Advances in Hereditary Colorectal Cancer: Opportunities and Challenges for Clinical Translation
    Bianca DeSouza, Demetra Georgiou · 2020 · Current Genetic Medicine Reports
  29. Colorectal Cancer
    Ad Geurts van Kessel, Ramprasath Venkatachalam, Roland P. Kuiper · 2012 · Elsevier eBooks
  30. Identification of candidate genes predisposing to familial colorectal cancer by germline whole exome sequencing
    Mei Sim Lung · 2019 · Minerva Access (University of Melbourne)
  31. Combinatorial approach of in silico and in vitro evaluation of MLH1 variant associated with Lynch syndrome like metastatic colorectal cancer
    Komal Saleem, Tahir Zaib, Wei Ji, Chunhui Zhang, Qian Qin, Yusi Wang, Lidan Xu, Hanfei Yu, Siqi Zhu, Kexian Dong et al. · 2020 · Bioscience Reports · Retracted
  32. Current perspective on the treatment of advanced/metastatic colorectal cancer
    Stanislav John · 2020 · Onkologie
  33. Lynch Syndrome-Associated Urological Malignancies
    Hisashi Hasumi, Masahiro Yao · 2020 · Springer eBooks
  34. Tumour development in Lynch syndrome : genes load the gun, lifestyle pulls the trigger?
    Jesca G.M. Brouwer · 2020
  35. E-cadherin and APC in early-onset colorectal cancer
    Alan Aitchison · 2020 · Otago University Research Archive (University of Otago)
  36. Contribuição das variantes missense e não codificantes dos gener BRCA1/2 para a predisposição hereditária e resposta ao tratamento dos cânceres de mama e ovário
    Elizabeth Santana Dos Santos · 2020
  37. Knockdown by MSH2 and EPCAM siRNA suppress Wnt/β-Catenin Pathway in HCT116 Cell Line
    Wan Khairunnisa Wan Juhari, Khairul Bariah Ahmad Amin Noordin, Wan Faiziah Wan Abdul Rahman, Andee Dzulkarnaen Zakaria, Wan Muhammad Mokhzani Wan Muhammad Mokhter, Bin Alwi Zilfalil · 2021 · Research Square
  38. Histopathological Findings in Prophylactic Surgical Specimens
    Fatma Hüsniye Dılek, Dilara İrem Arslan Kahraman · 2021 · Springer eBooks
  39. THE IMMUNOHISTOCHEMICAL EXPRESSIONS OF MISMATCH REPAIR GENES MLH1, PMS2, MSH6, MSH2 IN GASTRIC CANCER; A TISSUE MICROARRAY STUDY
    Gamze Erkılınç, Nermin Karahan, Şirin Başpınar, Zümrüt Arda KAYMAK, Şehnaz Evrimler · 2021 · SDÜ Tıp Fakültesi Dergisi
  40. T形スプリングを用いた歯列の一括移動におけるループ位置,トランスパラタルアーチ,臼歯列の歯数の影響 : 有限要素法による解析
    純 河村, 之夫 小島, 壽男 福井 · 2013 · 日本歯科理工学会誌
  41. Familial Syndromes
    Isabelle Ferry, Saira B. Alli, James T. Rutka · 2018 · Springer eBooks
  42. Hypermethylation of RAD9A intron 2 in childhood cancer patients and tumor cell lines
    Danuta Galetzka, Julia Böck, Marcus T. Dittrich, Iris M. Schmitt, Olesja Sinizyn, Marco Ludwig, Heidi Rossmann, Claudia Spix, Peter Scholz-Kreisel, Johanna Mirsch et al. · 2019 · Research Square
  43. Cancer of the Colon and Gastrointestinal Tract
    C Richard Boland, B. Jung, JM Carethers · 2014 · Elsevier eBooks
  44. Cancer Genetics
    Ian P.M. Tomlinson · 2009 · Springer eBooks
  45. Faculty Opinions recommendation of Identification of rare de novo epigenetic variations in congenital disorders.
    Heather C. Mefford · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  46. Prevalence of mismatch repair mutations in colorectal carcinoma patients in Mangalore
    Vineeth G Nair, Malak Shariff · 2022 · Indian Journal of Pathology and Oncology
  47. Germline multigene panel testing in gynecological cancer
    2022 · European Journal of Gynaecological Oncology
  48. Two Cases of Thymic Cancer in Patients with Lynch Syndrome
    Mototsugu Watanabe, Kohji Tanakaya, Shinichi Furukawa, Toshio Shiotani, Yumiko Sato, Fumitaka Taniguchi, Nobuhiko Kanaya, Hideki Aoki, Koukichi Sugano, Hideyuki Ishida et al. · 2022 · Internal Medicine
  49. Caracterización de la pérdida del gen NOMO1 en cáncer colorrectal
    Abel Martel-Martel · 2022
  50. Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient
    Mehmet Sitki Copur, Soe Min Tun, Luciano M. Vargas, Shaheed Merani, Whitney R. Wedel, Randy Duckert, Adam J. Horn, Nicholas J. Lintel, Daniel Herold, Swathi Lavudi · 2022 · Clinical Colorectal Cancer
  51. Risk Assessment and Prevention Strategies for Hereditary Gynecological Cancers
    Sayaka Ueno, Akira Hirasawa · 2022 · Comprehensive gynecology and obstetrics
  52. Caracterização molecular de tumores de endométrio quanto à proficiência do sistema de reparo de pareamento incorreto de DNA
    Reginaldo Cruz Alves Rosa · 2018
  53. Data from Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
    Robert A. Edwards, Mavee Witherspoon, Kehui Wang, Kambiz Afrasiabi, Trang Pham, Lutz Birnbaumer, Steven M. Lipkin · 2023
  54. Data from Micromanaging the Classification of Colon Cancer: The Role of the microRNAome
    Eduardo Vilar, Josep M. Tabernero, Stephen B. Gruber · 2023
  55. Data from Frequency of Rearrangements in Lynch Syndrome Cases Associated with MSH2: Characterization of a New Deletion Involving both EPCAM and the 5′ Part of MSH2
    Lucía Pérez‐Cabornero, Mar Infante Sanz, Eladio A. Velasco, Enrique Lastra Aras, Alberto Acedo Becares, Cristina Miner Pino, Mercedes Durán Domínguez · 2023
  56. Data from Frequency of Rearrangements in Lynch Syndrome Cases Associated with MSH2: Characterization of a New Deletion Involving both EPCAM and the 5′ Part of MSH2
    Lucía Pérez‐Cabornero, Mar Infante Sanz, Eladio A. Velasco, Enrique Lastra Aras, Alberto Acedo Becares, Cristina Miner Pino, Mercedes Durán Domínguez · 2023
  57. Genetic etiology of DNA-mismatch repair deficiency in cancer
    Reginaldo Cruz Alves Rosa · 2022
  58. Clasificación molecular del cáncer colorrectal, su impacto pronóstico y terapéutico: un paso crucial hacia la medicina personalizada
    Jaime González M, Guillermo Valenzuela T, Mónica Ahumada, Olga Barajas, Katherine Marcelain · 2020 · Revista Hospital Clínico Universidad de Chile
  59. Hereditäre kolorektale Karzinogenese
    Hendrik Bläker · 2023 · Die Pathologie
  60. A Case of Lynch Syndrome-Associated Colorectal Adenocarcinoma in a 19-Year-Old Female Patient
    Aimen Iqbal, Sandra K Rabat, Ravleen Kaur, Muhammad Salman Waqas, Sanya Badar, Faryal Haider, Muneebuddin Syed, Linda Thomas · 2023 · Cureus
  61. Clinical Features of Pancreas and Biliary Tract Cancers Related to Lynch Syndrome
    Yoon Suk Lee · 2023 · Journal of Digestive Cancer Research
  62. Genetic evaluation of the patients with colorectal cancer: rare variations and their role in the family follow-up program
    Igor O. Islanov, К.N. Petrenko, E. N. Levchenko, Elena V. Zaklyazminskaya, Arcady L. Bedzhanyan · 2023 · Clinical and Experimental Surgery Petrovsky journal
  63. Additional file 4 of Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome
    Anthony J. Scott, Felicia Hernandez, Adam C. Chamberlin, Cathy Smith, Rachid Karam, Jacob Otto Kitzman · 2023 · Figshare
  64. Additional file 1 of A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients
    Kai Zheng, Wan, Hua, Zhang, Jie, Guangyu Shan, Ningning Chai, Li, Dongdong, Nan Fang, Lina Liu, Jingbo Zhang, Rong Du et al. · 2020 · Figshare
  65. Additional file 3 of Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome
    Anthony J. Scott, Felicia Hernandez, Adam C. Chamberlin, Cathy Smith, Rachid Karam, Jacob Otto Kitzman · 2023 · Figshare
  66. Endometrial Carcinoma. Low-Grade Endometrioid Carcinoma
    Elena Lucas, Anne M. Mills, Kelley S. Carrick · 2024 · Springer eBooks
  67. BRAF-mutant mismatch repair deficient invasive colon cancer regressing to sessile serrated lesion
    Kenshi Matsuno, Hideaki Miyamoto, Miki Shimoda, Ryosuke Gushima, Katsuya Nagaoka, Mayuko Ohuchi, Yuji Miyamoto, Kohei Ohkura, Yoshiki Mikami, Yasuhito Tanaka · 2024 · Clinical Journal of Gastroenterology
  68. Lynch Syndrome
    Samara B. Rifkin, Elena M. Stoffel · 2024 · Elsevier eBooks
  69. Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer
    Jussi Nikkola, Lauri Ryyppö, Juuso Vuorinen, Lauri Moilanen, Maarit Ahtiainen, Kirsi Pylvänäinen, Hanna Selin, Tuomo Virtanen, Matti Nykter, Thea Veitonmäki et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations
    Paula Climent‐Cantó, Marc Subirana-Granés, Mireia Ramos-Rodríguez, Estela Dámaso, Fátima Marín, Covadonga Vara, Beatriz Pérez-González, Helena Raurell, Elisabet Munté, José Luís Soto et al. · 2024 · Clinical Epigenetics
  71. Germline structural variant as the cause of Lynch Syndrome in a family from Ecuador
    Gemma Llargués‐Sistac, Laia Bonjoch, Jenifer Muñoz, Xavier Domínguez‐Rovira, Teresa Ocaña, María Isabel Álvarez‐Mora, Célia Bádenas, Anna Esteve‐Codina, Carlos Alberto Reyes-Silva, Gabriela Jaramillo-Koupermann et al. · 2025 · npj Genomic Medicine
  72. Central and peripheral nervous system tumor predisposition syndromes
    Ana Guerreiro Stücklin, Uri Y. Tabori, Cynthia E Hawkins · 2025
  73. Lynch Syndrome
    James S. Wu, Brandie Leach, Charis Eng, David Hernández Gonzalo, Eric W. Willis · 2025 · Springer eBooks
  74. Abnormal Nuclear Membranous Staining Pattern by MLH1 Immunohistochemistry in Endometrial Cancer: A Diagnostic Pitfall and Clone-dependent Artifact
    Lisha Wang, David Jou, Ruchi Kshatri Patel, Grace L. Malvar, Katharine A. Germansky, Jonathan L. Hecht, Monika Vyas · 2025 · International Journal of Gynecological Pathology
  75. Contemporary insights into the molecular mechanisms of development and genetic susceptibility to pancreatic cancer
    A. D. Speridonova, Aliya Ramilevna Zaripova, I. R. Gilyazova, Marina Bermisheva · 2025 · Siberian Journal of Oncology
  76. Clinical Significance of EPCAM Pathogenic Germline Variant
    Jun-Ha Jang, Kyoung Bo Kim, Jong Eun Park, Mi‐Ae Jang, Dongju Won, Boyoung Park, Jung‐Sook Ha, Sun‐Young Kong · 2025 · Laboratory Medicine Online
  77. Mosaicism in genetic tumour syndromes
    Matej Boros, Franck Bourdeaut, Lara S. Fleischmann, Reiner Siebert, Susanne Bens · 2025 · Medizinische Genetik
  78. Transposable Elements in Cancer
    Sulev Kõks · 2025 · Epigenetics and human health
  79. Additional file 2 of Patients with unexplained mismatch repair deficiency are interested in updated genetic testing
    Jessica Omark, Eduardo Vilar, You, Y Nancy, Leslie A. Dunnington, Sarah Jane Noblin, Blair Stevens, Mork, Maureen · 2020 · Figshare
  80. Additional file 2 of Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome
    Anthony J. Scott, Felicia Hernandez, Adam C. Chamberlin, Smith, Cathy, Rachid Karam, Jacob Otto Kitzman · 2023 · Figshare
  81. Additional file 3 of Assessment of tumor suppressor promoter methylation in healthy individuals
    Poduval, Deepak B., Elisabet Ognedal, Zuzana Sichmanova, Eivind Valen, Gjertrud T. Iversen, Laura Minsaas, Per Eystein Lønning, Stian Knappskog · 2020 · Figshare
  82. Additional file 1 of Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
    Felicia Adam, Muriel Fluri, Amina Scherz, Manuela Rabaglio · 2024 · Figshare
  83. Additional file 5 of Assessment of tumor suppressor promoter methylation in healthy individuals
    Poduval, Deepak B., Elisabet Ognedal, Zuzana Sichmanova, Eivind Valen, Gjertrud T. Iversen, Laura Minsaas, Per Eystein Lønning, Stian Knappskog · 2020 · Figshare
  84. Additional file 1 of A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome
    Romy Walker, Mahmood, Khalid, JiHoon E. Joo, Mark Clendenning, Peter Georgeson, Julia Como, Sharelle L. Joseland, Susan Preston, Antill, Yoland, Rachel Austin et al. · 2023 · Figshare
  85. Additional file 2 of Assessment of tumor suppressor promoter methylation in healthy individuals
    Poduval, Deepak B., Elisabet Ognedal, Zuzana Sichmanova, Eivind Valen, Gjertrud T. Iversen, Laura Minsaas, Per Eystein Lønning, Stian Knappskog · 2020 · Figshare
  86. Additional file 1 of Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study
    Karolin Bucksch, Silke Zachariae, Aretz, Stefan, Büttner, Reinhard, Holinski-Feder, Elke, Stefanie Holzapfel, Robert Hüneburg, Matthias Kloor, Magnus von Knebel Doeberitz, Monika Morak et al. · 2020 · Figshare
  87. Additional file 1 of Patients with unexplained mismatch repair deficiency are interested in updated genetic testing
    Jessica Omark, Eduardo Vilar, You, Y Nancy, Leslie A. Dunnington, Sarah Jane Noblin, Blair Stevens, Mork, Maureen · 2020 · Figshare
  88. Additional file 2 of Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
    Felicia Adam, Fluri, Muriel, Amina Scherz, Manuela Rabaglio · 2024 · Figshare
  89. Additional file 5 of Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome
    Anthony J. Scott, Felicia Hernandez, Adam C. Chamberlin, Smith, Cathy, Rachid Karam, Jacob Otto Kitzman · 2023 · Figshare
  90. Additional file 1 of Assessment of tumor suppressor promoter methylation in healthy individuals
    Poduval, Deepak B., Elisabet Ognedal, Zuzana Sichmanova, Eivind Valen, Gjertrud T. Iversen, Laura Minsaas, Per Eystein Lønning, Stian Knappskog · 2020 · Figshare
  91. Additional file 3 of Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
    Felicia Adam, Muriel Fluri, Amina Scherz, Manuela Rabaglio · 2024 · Figshare
  92. Hereditary Aspects of Endometrial Cancer
    Takashi Mitamura · 2025 · Comprehensive gynecology and obstetrics
  93. Quality-Control Study Evaluating the Identification, Family History Collection, and Genetic Counseling Referral of Individuals At-Risk for HNPCC (Lynch Syndrome) Within the University of Pittsburgh Medical Center System and Applications to a State-Wide Referral System
    Andrew Sardella · 2012 · D-Scholarship@Pitt (University of Pittsburgh)
  94. Accessing the DNA in Breast Tissue: Adhesive Cell Capture from Flow onto Fibers of Cellulose Papers
    Sihang Chen, Eva P. Browne, Kathleen F. Arcaro, Maria M. Santore · 2026 · ACS Applied Materials & Interfaces
  95. Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot study
    Ellis L. Eikenboom, Joséphine Magnin, Remo Alessandris, Natally de Souza Maciel Rocha Horvat, Mithat Gonen, William R. Jarnagin, Jeffrey A. Drebin, Michael Ian D'Angelica, T. Peter Kingham, Vinod P. Balachandran et al. · 2026 · Frontiers in Oncology
  96. Bases moléculaires des diarrhées syndromiques(syndrome tricho-hépato-entérique)
    Alexandre Fabre · 2012
  97. Analyse génomique intégrée du cancer colique et impact thérapeutique
    Sophy Laibe · 2013
  98. Étude de l'impact des microARNs sur la carcinogenèse des cancers colorectaux instables sur les séquences répétées microsatellites du génome
    Nizar El-Murr · 2014 · theses.fr (ABES)
  99. Caractérisation des variations génétiques constitutionnelles de signification inconnue dans le syndrome de Lynch
    Philippe Grandval · 2014
  100. Induction d'un processus d'instabilité des microsatellites du génome dans des modèles murin et cellulaire : intérêt physiopathologique et clinique
    Sahra Bodo · 2014 · theses.fr (ABES)